Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swiss GO Trial Group is a non-profit academic research organization based in Basel, Switzerland, dedicated to advancing clinical research in gynecologic oncology. Founded in 2019, the group coordinates and sponsors investigator-initiated trials (IITs) and collaborates on international studies to improve treatment outcomes for patients with gynecological cancers. Swiss-GO is a member of the European Network for Gynaecological Oncological Trial groups (ENGOT) and the Gynecologic Cancer InterGroup (GCIG), focusing on precision medicine and innovative therapeutic approaches. The organization serves as a platform for clinicians and researchers to develop "out-of-the-box" diagnostic and therapeutic strategies, particularly for indications such as ovarian, endometrial, and cervical cancers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swiss GO Trial Group.